EAM Investors, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$1,700,000
-25.9%
11,779
+4.9%
0.53%
+4.6%
Q4 2019$2,295,000
+212.2%
11,228
+22.7%
0.50%
+160.3%
Q3 2019$735,000
-73.1%
9,150
-68.4%
0.19%
-71.0%
Q2 2019$2,730,000
-15.8%
28,933
-23.7%
0.67%
-16.0%
Q1 2019$3,241,000
+54.5%
37,917
+1.4%
0.80%
+39.5%
Q4 2018$2,098,000
-59.4%
37,406
-40.8%
0.57%
-25.8%
Q3 2018$5,165,00063,1770.77%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders